Hyperbilirubinemia’s protective effect against cisplatin nephrotoxicity in the Gunn rat

por Barabas, Karri, Milner, Rowan, Farese, James, Baylis, Chris, Croker, Byron, Archer, Linda, Adin, Christopher
Publicado en Anticancer Drugs (2008)

IMMU-47. RNA-NANOPARTICLE VACCINES ARE SAFE AND IMMUNOLOGICALLY ACTIVE IN CLIENT-OWNED CANINES WITH TERMINAL GLIOMAS

por Carrera-Justiz, Sheila, Stover, Brian, Milner, Rowan, Weidert, Frances, Huang, Jianping, Mitchell, Duane, Mendez-Gomez, Hector, Sayour, Elias
Publicado en Neuro Oncol (2019)

GD2 chimeric antigen receptor modified T cells in synergy with sub-toxic level of doxorubicin targeting osteosarcomas

por Chulanetra, Monrat, Morchang, Atthapan, Sayour, Elias, Eldjerou, Lamis, Milner, Rowan, Lagmay, Joanne, Cascio, Matt, Stover, Brian, Slayton, William, Chaicumpa, Wanpen, Yenchitsomanus, Pa-Thai, Chang, Lung-Ji
Publicado en Am J Cancer Res (2020)

Novel application of single-cell next-generation sequencing for determination of intratumoral heterogeneity of canine osteosarcoma cell lines

por Ayers, Jordan, Milner, Rowan J., Cortés-Hinojosa, Galaxia, Riva, Alberto, Bechtel, Sandra, Sahay, Bikash, Cascio, Matthew, Lejeune, Amandine, Shiomitsu, Keijiro, Souza, Carlos, Hernandez, Oscar, Salute, Marc
Publicado en J Vet Diagn Invest (2021)